ENO1 and breast cancer: Elevated levels of NEAT1 in breast cancer enhance glycolysis by scaffolding key glycolytic enzymes, including PGK1, PGAM1, and ENO1, concurrently within the same cellular context, thereby promoting breast cancer progression and metabolism [41].